This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
Researchers studied the effects of Ivermectin (IVM) on patients with drug-resistant epilepsy, which means their seizures are hard to control even with multiple medications.
Researchers studied how deep brain stimulation (DBS) and responsive neurostimulation (RNS) can help people with drug-resistant epilepsy (DRE), which is epilepsy that doesn’t respond to medications.
This study looked at a group of Japanese patients with specific genetic changes known as DHDDS variants, which are linked to severe epilepsy and movement disorders.
This study looked at how two different surgical methods for treating drug-resistant mesial temporal lobe epilepsy affect thinking skills, particularly memory and naming abilities.
Researchers studied the use of a medication called perampanel, which is already approved for treating seizures in epilepsy, to see if it could help people with severe tremors.
This study looked at Tuberous Sclerosis Complex (TSC), a rare genetic disorder, in Greece.
This study looked at the effects of resective surgery on children with drug-resistant epilepsy related to tuberous sclerosis complex (TSC).
Researchers studied a condition called infantile and epileptic spasms syndrome (IESS), which affects infants and can lead to serious developmental issues.
Researchers studied the effectiveness of trigeminal nerve stimulation (TNS) as a treatment for people with drug-resistant epilepsy (DRE), which means their seizures do not respond to standard medications.